Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis

Motokazu Sugimoto, Naoki Takahashi, Michael B. Farnell, Thomas C. Smyrk, Mark J. Truty, David M. Nagorney, Rory L. Smoot, Suresh T. Chari, Rickey E. Carter, Michael L. Kendrick

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences